Insights into the role of immunosenescence during varicella zoster virus infection (shingles) in the aging cell model

Oncotarget

Volumn 6, Issue 34, 2015, Pages 35324-35343

  Kim, Ji Ae ^a   Park, Seul Ki ^a   Kumar, Mukesh ^b   Lee, Chan Hee ^c   Shin, Ok Sarah ^a  

^a Korea University College of Medicine   (South Korea)

^b UNIVERSITY OF HAWAII   (United States)

^c Chungbuk National University   (South Korea)

Author keywords

Gerotarget; Immunosenescence; Progeria; Shingles; STING; VZV

Indexed keywords

CRYOPYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR; TRANSCRIPTOME;

AGING; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; GENE EXPRESSION REGULATION; HERPES ZOSTER; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; NONHUMAN; PHENOTYPE; PROGERIA; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; RNA SEQUENCE; SENESCENCE; UPREGULATION; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS TITRATION; CHILD; IMMUNOLOGY; IMMUNOSENESCENCE; PHYSIOLOGY; PRESCHOOL CHILD; VARICELLA ZOSTER VIRUS; VIROLOGY;

CHILD; CHILD, PRESCHOOL; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOSENESCENCE; PROGERIA; VIRUS REPLICATION;

EID: 84946887830     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.6117     Document Type: Article

References (42)

1. Zerboni L, Sen N, Oliver SL and Arvin AM. Molecular mechanisms of varicella zoster virus pathogenesis. Nature reviews Microbiology. 2014; 12:197-210.
2. Diaz PS, Smith S, Hunter E and Arvin AM. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine. Journal of immunology. 1989; 142:636-641.
3. Shapiro M, Kvern B, Watson P, Guenther L, McElhaney J and McGeer A. Update on herpes zoster vaccination: a family practitioner's guide. Canadian family physician Medecin de famille canadien. 2011; 57:1127-1131.
4. Raeder CK and Hayney MS. Immunology of Varicella Immunization in the elderly. The Annals of pharmacotherapy. 2000; 34:228-234.
5. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446.
6. Solana R, Tarazona R, Gayoso I, Lesur O, Dupuis G and Fulop T. Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Seminars in immunology. 2012; 24:331-341.
7. Marin M, Yawn BP, Hales CM, Wollan PC, Bialek SR, Zhang J, Kurland MJ and Harpaz R. Herpes Zoster Vaccine Effectiveness and Manifestations of Herpes Zoster and Associated Pain by Vaccination Status. Human vaccines & immunotherapeutics. 2015:0.
8. DeBusk FL. The Hutchinson-Gilford progeria syndrome. Report of 4 cases and review of the literature. The Journal of pediatrics. 1972; 80:697-724.
9. Gordon LB, Brown WT and Collins FS. (1993). Hutchinson-Gilford Progeria Syndrome. In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH and Stephens K, eds. GeneReviews(R). (Seattle (WA).
10. Aliper AM, Csoka AB, Buzdin A, Jetka T, Roumiantsev S, Moskalev A and Zhavoronkov A. Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells. Aging. 2015; 7:26-37.
11. Goldman RD, Shumaker DK, Erdos MR, Eriksson M, Goldman AE, Gordon LB, Gruenbaum Y, Khuon S, Mendez M, Varga R and Collins FS. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101:8963-8968.
12. Viteri G, Chung YW and Stadtman ER. Effect of progerin on the accumulation of oxidized proteins in fibroblasts from Hutchinson Gilford progeria patients. Mechanisms of ageing and development. 2010; 131:2-8.
13. Paradisi M, McClintock D, Boguslavsky RL, Pedicelli C, Worman HJ and Djabali K. Dermal fibroblasts in Hutchinson-Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress. BMC cell biology. 2005; 6:27.
14. Gavazzi G and Krause KH. Ageing and infection. The Lancet Infectious diseases. 2002; 2:659-666.
15. Mei B, Ding X, Xu HZ and Wang MT. Global gene expression changes in human peripheral blood after H7N9 infection. Gene. 2014; 551:255-260.
16. Wang Y, Lupiani B, Reddy SM, Lamont SJ and Zhou H. RNA-seq analysis revealed novel genes and signaling pathway associated with disease resistance to avian influenza virus infection in chickens. Poultry science. 2014; 93:485-493.
17. Ertl R and Klein D. Transcriptional profiling of the host cell response to feline immunodeficiency virus infection. Virology journal. 2014; 11:52.
18. Jones M, Dry IR, Frampton D, Singh M, Kanda RK, Yee MB, Kellam P, Hollinshead M, Kinchington PR, O'Toole EA and Breuer J. RNA-seq analysis of host and viral gene expression highlights interaction between varicella zoster virus and keratinocyte differentiation. PLoS pathogens. 2014; 10:e1003896.
19. Rossetto CC, Tarrant-Elorza M, Verma S, Purushothaman P and Pari GS. Regulation of viral and cellular gene expression by Kaposi's sarcoma-associated herpesvirus polyadenylated nuclear RNA. Journal of virology. 2013; 87:5540-5553.
20. Juranic Lisnic V, Babic Cac M, Lisnic B, Trsan T, Mefferd A, Das Mukhopadhyay C, Cook CH, Jonjic S and Trgovcich J. Dual analysis of the murine cytomegalovirus and host cell transcriptomes reveal new aspects of the virus-host cell interface. PLoS pathogens. 2013; 9:e1003611.
21. Korf B. Hutchinson-Gilford progeria syndrome, aging, and the nuclear lamina. The New England journal of medicine. 2008; 358:552-555.
22. Lee BY, Han JA, Im JS, Morrone A, Johung K, Goodwin EC, Kleijer WJ, DiMaio D and Hwang ES. Senescenceassociated beta-galactosidase is lysosomal betagalactosidase. Aging cell. 2006; 5:187-195.
23. Won YH, Kim JI, Kim YY and Lee CH. Characterization of the Repeat Sequences of Varicella-Zoster Virus. Journal of Bacteriology and Virology. 2014; 44:326-335.
24. Cristofalo VJ and Pignolo RJ. Replicative senescence of human fibroblast-like cells in culture. Physiological reviews. 1993; 73:617-638.
25. Konno H and Barber GN. The STING controlled cytosolicDNA activated innate immune pathway and microbial disease. Microbes and infection/Institut Pasteur. 2014; 16:998-1001.
26. McElhaney JE. Herpes zoster: a common disease that can have a devastating impact on patients' quality of life. Expert review of vaccines. 2010; 9:27-30.
27. Zhu H, Zheng C, Xing J, Wang S, Li S, Lin R and Mossman KL. Varicella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3. Journal of virology. 2011; 85:11079-11089.
28. Vandevenne P, Lebrun M, El Mjiyad N, Ote I, Di Valentin E, Habraken Y, Dortu E, Piette J and Sadzot-Delvaux C. The varicella-zoster virus ORF47 kinase interferes with host innate immune response by inhibiting the activation of IRF3. PloS one. 2011; 6:e16870.
29. Sen N, Sommer M, Che X, White K, Ruyechan WT and Arvin AM. Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesviruses. Journal of virology. 2010; 84:9240-9253.
30. Merideth MA, Gordon LB, Clauss S, Sachdev V, Smith AC, Perry MB, Brewer CC, Zalewski C, Kim HJ, Solomon B, Brooks BP, Gerber LH, Turner ML, et al. Phenotype and course of Hutchinson-Gilford progeria syndrome. The New England journal of medicine. 2008; 358:592-604.
31. McClintock D, Ratner D, Lokuge M, Owens DM, Gordon LB, Collins FS and Djabali K. The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin. PloS one. 2007; 2:e1269.
32. Roe K, Gibot S and Verma S. Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity? Frontiers in microbiology. 2014; 5:627.
33. Concha M, Wang X, Cao S, Baddoo M, Fewell C, Lin Z, Hulme W, Hedges D, McBride J and Flemington EK. Identification of new viral genes and transcript isoforms during Epstein-Barr virus reactivation using RNA-Seq. Journal of virology. 2012; 86:1458-1467.
34. Metcalf TU, Cubas RA, Ghneim K, Cartwright MJ, Grevenynghe JV, Richner JM, Olagnier DP, Wilkinson PA, Cameron MJ, Park BS, Hiscott JB, Diamond MS, Wertheimer AM, et al. Global analyses revealed age-related alterations in innate immune responses after stimulation of pathogen recognition receptors. Aging cell. 2015; 14:421-432.
35. Samuel MA and Diamond MS. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. Journal of virology. 2005; 79:13350-13361.
36. Rodier F, Coppe JP, Patil CK, Hoeijmakers WA, Munoz DP, Raza SR, Freund A, Campeau E, Davalos AR and Campisi J. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nature cell biology. 2009; 11:973-979.
37. Iwasa H, Han J and Ishikawa F. Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes to cells: devoted to molecular & cellular mechanisms. 2003; 8:131-144.
38. Li Q, Ali MA and Cohen JI. Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread. Cell. 2006; 127:305-316.
39. Abe T and Barber GN. Cytosolic-DNA-mediated, STINGdependent proinflammatory gene induction necessitates canonical NF-kappaB activation through TBK1. Journal of virology. 2014; 88:5328-5341.
40. Holm CK, Jensen SB, Jakobsen MR, Cheshenko N, Horan KA, Moeller HB, Gonzalez-Dosal R, Rasmussen SB, Christensen MH, Yarovinsky TO, Rixon FJ, Herold BC, Fitzgerald KA, et al. Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING. Nature immunology. 2012; 13:737-743.
41. Nazmi A, Mukhopadhyay R, Dutta K and Basu A. STING mediates neuronal innate immune response following Japanese encephalitis virus infection. Scientific reports. 2012; 2:347.
42. Mitzel DN, Lowry V, Shirali AC, Liu Y and StoutDelgado HW. Age-enhanced endoplasmic reticulum stress contributes to increased Atg9A inhibition of STINGmediated IFN-beta production during Streptococcus pneumoniae infection. Journal of immunology. 2014; 192:4273-4283.